Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

CLINICA 100 TOP 10: Roche Diagnostics

This article was originally published in Clinica

Executive Summary

Roche Diagnostics remains at No 6 in our Clinica 100 and continues to hold on as leader of the IVD sector. While not the most acquisitive buyer, Roche has been a consistent shopper, adding mainly smaller, bolt-on technologies to its molecular diagnostics offering. In 2014, it made six acquisitions, mostly of undisclosed amounts or under $500m. It made the same number of acquisition in 2015, but it dug deeper in its pocket this year and signed a deal worth up to $1.2bn to gain a majority stake in Foundation Medicine, a molecular information and genomic analysis firm. See how Roche Diagnostics performed in the last five years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register